A Modified Prescription-Event Monitoring Study to Assess the Introduction of Seretide Evohaler™ in England: An Example of Studying Risk Monitoring in Pharmacovigilance

By Perrio Michael J.   Wilton Lynda V.   Shakir Saad A.W.  

Drug Safety, Vol. 30, Iss. 8, 2007-01 ,pp. : 681-695

Adis International

Access to resources Recommend Favorite

Use and Risk Management of Carvedilol for the Treatment of Heart Failure in the Community in England: Results from a Modified Prescription-Event Monitoring Study

By Aurich-Barrera Beate   Wilton Lynda V.   Shakir Saad A.W.  

Drug Safety, Vol. 32, Iss. 1, 2009-01 ,pp. : 43-54

Adis International

Access to resources Recommend Favorite

Drug Utilization of Intrinsa® (Testosterone Patch) in England: Interim Analysis of a Prescription-Event Monitoring Study to Support Risk Management

By Osborne Vicki   Hazell Lorna   Layton Deborah   Shakir Saad A.W.  

Drug Safety, Vol. 33, Iss. 3, 2010-03 ,pp. : 213-221

Adis International

Access to resources Recommend Favorite

Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine: A Prescription-Event Monitoring Study in England

By Layton Deborah   Wilton Lynda   Boshier Andrew   Cornelius Victoria  

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 897-909

Adis International

Access to resources Recommend Favorite

Monitoring the Safety of Pioglitazone: Results of a Prescription-Event Monitoring Study of 12 772 Patients in England

By Kasliwal Rachna   Wilton Lynda V.   Shakir Saad A.W.  

Drug Safety, Vol. 31, Iss. 10, 2008-01 ,pp. : 839-850

Adis International

Access to resources Recommend Favorite